{"id":"51de0c80-3bd9-45b6-96e2-3ed8c6121123","modelId":"cbddf8cc-09f3-4af7-a462-f04756e87318","versionId":null,"locationId":"420e256b-1c3e-4a75-9ebf-06dc662e005c","operatorId":"4421900a-d71f-407e-a37c-ad1e3905e97f","ownerId":null,"slug":"rewalk-personal-home","status":"operational","firstSeen":"2014-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["autonomous_operation"],"shiftStructure":null,"hoursPerDay":8,"siteType":"home","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"consumer","siteEnvironment":"consumer","operatorType":"customer_deployed","sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://golifeward.com/products/rewalkpersonal-exoskeleton/","title":"ReWalk 7","source":"Lifeward","dateAccessed":"2026-08-08"}],"notes":"ReWalk Personal Exoskeleton — first exoskeleton approved by the FDA for home and community use.","keyFacts":[{"date":"2014-06-01","fact":"First FDA-approved home-use exoskeleton (2014)"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T23:40:51.408Z","updatedAt":"2026-10-10T23:38:31.800Z","model":{"id":"cbddf8cc-09f3-4af7-a462-f04756e87318","companyId":"4421900a-d71f-407e-a37c-ad1e3905e97f","modelName":"ReWalk Personal Exoskeleton","slug":"rewalk-personal","description":"FDA-cleared powered exoskeleton for home and community use by individuals with spinal cord injury. ReWalk 7 is the latest version.","formFactor":"exoskeleton","industryVertical":"healthcare","environment":"outdoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://golifeward.com/products/rewalkpersonal-exoskeleton/","title":"ReWalk 7 Personal Exoskeleton","source":"Lifeward","dateAccessed":"2026-08-08"}],"aliases":["ReWalk Personal"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Mobility (company-claimed)","value":"Powered hip and knee motion lets users with SCI stand, walk, turn, and climb and descend stairs and curbs, per Lifeward."},{"label":"US indications and Medicare (company-claimed)","value":"Indicated for SCI levels T7 to L5 at home and in the community with a certified companion; Medicare brace category from January 1, 2024."}],"createdAt":"2026-08-08T23:40:50.602Z","updatedAt":"2026-10-12T21:44:18.238Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"4421900a-d71f-407e-a37c-ad1e3905e97f","name":"Lifeward","slug":"lifeward","description":"Lifeward (formerly [Rewalk robotics](/companies/rewalk-robotics), Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.","status":"public","founded":2001,"hq":"Marlborough, MA, USA / Yokneam Ilit, Israel","hqLat":null,"hqLng":null,"hqGeocodedAt":"2026-08-05T00:51:10.902Z","hqAddress":null,"hqPrecision":null,"website":"alterg.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward","title":"Lifeward","sourceName":"Lifeward (primary)"},{"url":"https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/","title":"ReWalk Personal 6.0 FDA home-use","sourceName":"Lifeward (primary)"},{"url":"https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo","label":"Lifeward Names Mark Grant as New CEO","title":"Lifeward Names Mark Grant as New CEO","mediaType":"article","sourceName":"Lifeward (official IR)"},{"url":"https://golifeward.com/blog/lifeward-launches-sales-of-the-rewalk-7-personal-exoskeleton-in-u-s-market/","label":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","title":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","mediaType":"article","sourceName":"Lifeward (official)"},{"url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325000736/zk2532799.htm","label":"Lifeward Ltd. SEC Filing 2025","title":"Lifeward Ltd. SEC Filing 2025","mediaType":"article","sourceName":"SEC EDGAR"}],"keyFacts":[{"label":"CEO","value":"Mark Grant (since June 2025)"},{"label":"Previous CEO","value":"Larry Jasinski"},{"label":"CFO","value":"Mike Lawless"},{"label":"Founder","value":"Dr. Amit Goffer (deceased), quadriplegic Israeli inventor"},{"label":"Ticker","value":"NASDAQ: LFWD"},{"label":"Revenue 2024","value":"Approximately 25.3 million USD"},{"label":"Units deployed","value":"131 rehabilitation units + 689 personal exoskeleton units (as of Dec 2024)"},{"label":"FDA clearance","value":"ReWalk 7 cleared March 2025; first FDA-cleared exoskeleton in 2014"},{"label":"Medicare","value":"CMS reimbursement pathway established 2024"},{"label":"Operations","value":"United States, Israel, Germany"},{"label":"Product portfolio","value":"ReWalk 7, ReWalk Personal 6.0, AlterG Anti-Gravity, ReStore Exo-Suit, MyoCycle FES"}],"aliases":["ReWalk Robotics","ReWalk"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"LFWD","stockExchange":"NASDAQ","secCik":"0001607962","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:37.810Z","updatedAt":"2026-10-09T21:25:12.916Z"}},"version":null,"location":{"id":"420e256b-1c3e-4a75-9ebf-06dc662e005c","name":"Multiple, USA","slug":"multiple-usa","kind":"city","parentLocationId":null,"region":"North America","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":["Multiple locations, USA","Nationwide USA","Multiple US cities"],"collisionRisk":"high","reviewNote":"Virtual catch-all location for multi-site US deployments. Verified — Ekso Bionics Ekso Indego Personal home-use deployment across multiple US locations. FDA-cleared (T3-L5 SCI) powered exoskeleton for home and community use, covered by CMS Medicare reimbursement (April 2024) and VA benefits. Deployed nationwide through VA and clinics. Source: eksobionics.com/ekso-indego-personal.","createdAt":"2026-08-08T23:39:32.298Z","updatedAt":"2026-08-11T23:27:31.979Z"},"operator":{"id":"4421900a-d71f-407e-a37c-ad1e3905e97f","name":"Lifeward","slug":"lifeward","description":"Lifeward (formerly [Rewalk robotics](/companies/rewalk-robotics), Nasdaq: LFWD) is an Israeli-American medical device company founded in 2001 by Dr. Amit Goffer, a quadriplegic inventor who developed the exoskeleton after an ATV accident. The company designs and commercializes powered exoskeleton systems for individuals with spinal cord injury, including the ReWalk 7 Personal Exoskeleton (FDA-cleared March 2025) and the ReWalk Personal 6.0. Lifeward's portfolio also includes the AlterG Anti-Gravity System, ReStore Exo-Suit, and MyoCycle FES System, with operations in the US, Israel, and Germany.","status":"public","founded":2001,"hq":"Marlborough, MA, USA / Yokneam Ilit, Israel","hqLat":null,"hqLng":null,"hqGeocodedAt":"2026-08-05T00:51:10.902Z","hqAddress":null,"hqPrecision":null,"website":"alterg.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward","title":"Lifeward","sourceName":"Lifeward (primary)"},{"url":"https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/","title":"ReWalk Personal 6.0 FDA home-use","sourceName":"Lifeward (primary)"},{"url":"https://ir.rewalk.com/news-releases/news-release-details/lifeward-names-mark-grant-new-ceo","label":"Lifeward Names Mark Grant as New CEO","title":"Lifeward Names Mark Grant as New CEO","mediaType":"article","sourceName":"Lifeward (official IR)"},{"url":"https://golifeward.com/blog/lifeward-launches-sales-of-the-rewalk-7-personal-exoskeleton-in-u-s-market/","label":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","title":"Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market","mediaType":"article","sourceName":"Lifeward (official)"},{"url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891325000736/zk2532799.htm","label":"Lifeward Ltd. SEC Filing 2025","title":"Lifeward Ltd. SEC Filing 2025","mediaType":"article","sourceName":"SEC EDGAR"}],"keyFacts":[{"label":"CEO","value":"Mark Grant (since June 2025)"},{"label":"Previous CEO","value":"Larry Jasinski"},{"label":"CFO","value":"Mike Lawless"},{"label":"Founder","value":"Dr. Amit Goffer (deceased), quadriplegic Israeli inventor"},{"label":"Ticker","value":"NASDAQ: LFWD"},{"label":"Revenue 2024","value":"Approximately 25.3 million USD"},{"label":"Units deployed","value":"131 rehabilitation units + 689 personal exoskeleton units (as of Dec 2024)"},{"label":"FDA clearance","value":"ReWalk 7 cleared March 2025; first FDA-cleared exoskeleton in 2014"},{"label":"Medicare","value":"CMS reimbursement pathway established 2024"},{"label":"Operations","value":"United States, Israel, Germany"},{"label":"Product portfolio","value":"ReWalk 7, ReWalk Personal 6.0, AlterG Anti-Gravity, ReStore Exo-Suit, MyoCycle FES"}],"aliases":["ReWalk Robotics","ReWalk"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"LFWD","stockExchange":"NASDAQ","secCik":"0001607962","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:37.810Z","updatedAt":"2026-10-09T21:25:12.916Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/rewalk-personal-home","url":"https://registry.deploy.report/deployments/rewalk-personal-home","name":"ReWalk Personal Exoskeleton at Multiple, USA","identifier":"51de0c80-3bd9-45b6-96e2-3ed8c6121123","startDate":"2014-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/multiple-usa","name":"Multiple, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/lifeward","name":"Lifeward"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/rewalk-personal","name":"ReWalk Personal Exoskeleton"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}